Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Weider Soy Powder With Once-Daily Dosing Joining Schiff Line April 1

This article was originally published in The Tan Sheet

Executive Summary

Weider Nutrition will extend its Schiff line of products in April with the introduction of Soy One powdered drink mix, as well as MSM 500 and Glucosamine MSM Complex. The items debuted at the Natural Products Expo West show in Anaheim, Calif. March 23-26.

You may also be interested in...



Flexagen Joint Care "From The Makers of Advil " Hitting Shelves Now

Flexagen, a glucosamine/chondroitin joint care supplement, will be backed by a national TV and print ad campaign breaking in July, Whitehall-Robins announced at the National Association of Chain Drug Stores Marketplace in New Orleans June 25-28.

Flexagen Joint Care "From The Makers of Advil " Hitting Shelves Now

Flexagen, a glucosamine/chondroitin joint care supplement, will be backed by a national TV and print ad campaign breaking in July, Whitehall-Robins announced at the National Association of Chain Drug Stores Marketplace in New Orleans June 25-28.

Flexagen Joint Care "From The Makers of Advil " Hitting Shelves Now

Flexagen, a glucosamine/chondroitin joint care supplement, will be backed by a national TV and print ad campaign breaking in July, Whitehall-Robins announced at the National Association of Chain Drug Stores Marketplace in New Orleans June 25-28.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel